Clinical epidemiology of ulcerative colitis in Mexico: A single hospital-based study in a 20-year period (1987-2006)

Journal of Clinical Gastroenterology

Volumn 43, Issue 3, 2009, Pages 221-224

  Yamamoto Furusho, Jesús K ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Clinical; Epidemiology; Latin America; Mexico; UC

Indexed keywords

AZATHIOPRINE; MESALAZINE; SALAZOSULFAPYRIDINE; STEROID;

ADULT; ARTICLE; ENDOSCOPY; ETHNICITY; FEMALE; GEOGRAPHY; HEREDITY; HUMAN; INCIDENCE; INFECTION; MAJOR CLINICAL STUDY; MALE; MEXICO; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; ULCERATIVE COLITIS;

ADULT; AGE OF ONSET; AMINOSALICYLIC ACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AZATHIOPRINE; COHORT STUDIES; COLITIS, ULCERATIVE; ENVIRONMENT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HOSPITALS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INTESTINAL DISEASES, PARASITIC; MALE; MEXICO; MIDDLE AGED; PREVALENCE; SULFASALAZINE; YOUNG ADULT;

EID: 67650891855     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31817a76b4     Document Type: Article

References (24)

1. Loftus EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504-1517. (Pubitemid 38649869)
2. Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31:1-20.
3. Garrido A, Martinez MJ, Ortega JA, et al. Epidemiology of chronic inflammatory bowel disease in the Northern of Huelva. Rev Esp Enferm Dig. 2004;96:687-691.
4. Satsangi J, Silverberg MS, Vermiere S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749-753. (Pubitemid 43764536)
5. Salas SD. Intestinal parasites in Central American immigrants in the United States. Arch Intern Med. 1990;150:1514-1516.
6. Bernstein CN, Wajda A, Svenson LW, et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol. 2006;101:1559-1568. (Pubitemid 43980630)
7. Gheorhe C, Pascu O, Gheorghe L, et al. Epidemiology of inflammatory bowel disease in adults who refer to gastroenterology care in Romania: a multicentre study. Eur J Gastroenterol Hepatol. 2004;16:1153-1159. (Pubitemid 39488787)
8. Abdul-Baki H, El-Zahabi LM, Azar C, et al. Clinical epidemiology of inflammatory bowel disease in Lebanon. Inflamm Bowel Dis. 2006;13:475-480.
9. Haug K, Schrumpf E, Halvorsen JF, et al. Epidemiology of Crohn's disease in western Norway. Scand J Gastroenterol. 1989;24:1271-1275. (Pubitemid 20015808)
10. Sonnenberg A. Geographic variation in the incidence and mortality from inflammatory bowel disease. Dis Colon Rectum. 1986;29:1271-1275. (Pubitemid 17208886)
11. Jiang XL, Cui HF. An analysis of 10,218 ulcerative colitis cases in China. World J Gastroenterol. 2002;8:158-161.
12. Yang SK, Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis. 2001; 7:260-270. (Pubitemid 32776521)
13. Aghazadeh R, Zali MR, Bahari A, et al. Inflammatory bowel disease in Iran: a review of 457 cases. J Gastroenterol Hepatol. 2005;20:1691-1695. (Pubitemid 43961074)
14. Gower-Rousseau C, Salomez JL, Dupas JL, et al. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut. 1994;35:1433-1438.
15. Tallori G, d'Albasio G, Pali D, et al. Epidemiology of inflammatory bowel disease over a 10-year period in Florence (1978-1987). Ital J Gastroenterol. 1991;23: 559-563.
16. Henriksen M, Jahnsen J, Lygren I, et al. Ulcerative colitis and clinical course: results of a 5-year population based followup study (the IBSEN study). Inflamm Bowel Dis. 2006;12: 543-550. (Pubitemid 43977734)
17. Leijonmarck CE, Persson PG, Hellers G. Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut. 1990;31:239-1233 (Pubitemid 20093673)
18. Jess T, Loftus EV Jr, Velayos FS, et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted county, Minnesota. Gastroenterology. 2006;130:1039-1046.
19. Langholz E, Munkholm P, Davidsen M, et al. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology. 1992;103:1444-1451.
20. Munkholm P. The incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther. 2003;18:1-5. (Pubitemid 37174709)
21. Bernstein CN, Blanchard JF, Rawsthorne P, et al. The prevalence of extraintestinal diseases in inflammatory bowel disease. A population based study. Am J Gastroenterol. 2001;96: 1116-1122. (Pubitemid 32319146)
22. Kochhar R, Mehta SK, Nagi B, et al. Extraintestinal manifestations of idiopathic ulcerative colitis. Indian J Gastroenterol. 1991;10:88-89.
23. Park SM, Han DS, Yank SK, et al. Clinical features of ulcerative colitis in Korea. Korean J Intern Med. 1996;11: 9-17.
24. Olson R, Danielsson A, Jarnerot G, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology. 1991;100:1319-1323.